Liver Micro Flow - MRI
ConditionLiver Diseases
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age7+
SponsorUniversity of Wisconsin, Madison
About this trial
This study integrates and evaluates a series of novel MRI methods for quantifying blood perfusion and tissue microstructure. The proposed perfusion and microstructure measures may provide biomarkers for fibrosis, cirrhosis, portal hypertension, and response to treatment. The precision of these methods will be evaluated in 110 participants, including healthy volunteers, people with chronic liver disease (CLD), and people with liver fibrosis.
Eligibility criteria
Qualifiers
Age 7 years or older
Willing and able to complete study procedures
Disqualifiers
Patients with contraindication to MRI (e.g. pacemaker, contraindicated metallic implants, claustrophobia, etc)
Pregnant or trying to become pregnant (as determined by self-report during MRI safety screening)
Received ferumoxytol injection within previous one year (clinical or research)
The person has their own prescription for the medication.
Trial design
Treatments tested in this trial
- Novel MRI Software
- Ensure Plus Nutrition Shake
Treatment groups
110 Participants
are divided into 3 treatment groupsLocations
1University of Wisconsin53792, MadisonWisconsin, United States
Sponsors and collaborators
University of Wisconsin, Madison
Lead sponsor
National Institute for Biomedical Imaging and Bioengineering (NIBIB)
Collaborator
Source ClinicalTrials.gov